PLAUR and oral cavity squamous cell carcinoma: The expression of uPAR is an important reason for cetuximab resistance in patients with oral squamous cell carcinoma, and combination therapy with resveratrol, which can inhibit the expression of uPAR, may provide an attractive means for treating these patients 182.